The honest clinical picture is cautious: DSIP is investigational and research-only , much of the existing human data is older, limited, and inconsistent , and the available trials point in conflicting directions
Additionally, in the SELECT trial, adults with obesity and without diabetes receiving semaglutide had a 20% lower risk for major adverse CV events compared with placebo (HR = 0.8
4 The easing of nausea after the first weeks of treatment is consistent with, but does not prove, such adaptation
Inside this molecule, the incretin arms counterbalance that effect, and the net result in trials was strong glucose control plus an extra energy-expenditure component
The influencers, including RFK Jr., are abusing the system and not following the science. David Cutler, MD, a family medicine physician at Providence Saint Johns Health Center in California, is also adamantly opposed to easing restrictions on these peptides